Angiography Devices

Global Angiography Devices Market to Reach US$15.1 Billion by 2030

The global market for Angiography Devices estimated at US$12.0 Billion in the year 2024, is expected to reach US$15.1 Billion by 2030, growing at a CAGR of 3.9% over the analysis period 2024-2030. Angiography Systems, one of the segments analyzed in the report, is expected to record a 5.2% CAGR and reach US$5.8 Billion by the end of the analysis period. Growth in the Angiography Contrast Media segment is estimated at 3.8% CAGR over the analysis period.

The U.S. Market is Estimated at US$3.1 Billion While China is Forecast to Grow at 6.8% CAGR

The Angiography Devices market in the U.S. is estimated at US$3.1 Billion in the year 2024. China, the world`s second largest economy, is forecast to reach a projected market size of US$3.5 Billion by the year 2030 trailing a CAGR of 6.8% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 1.0% and 2.8% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 1.9% CAGR.

Global Angiography Devices Market - Key Trends & Drivers Summarized

Why Is the Demand for Angiography Devices Surging in Cardiovascular Healthcare?

Angiography devices are experiencing a surge in demand, driven primarily by the increasing prevalence of cardiovascular diseases (CVD) globally. As heart disease remains a leading cause of mortality worldwide, diagnostic procedures like angiography, which provide detailed images of blood vessels, are critical for early detection and treatment. The aging global population, along with unhealthy lifestyle habits such as poor diet and lack of exercise, has led to a rise in conditions like atherosclerosis, stroke, and coronary artery disease. Consequently, the need for reliable diagnostic tools, including angiography systems, is becoming more pronounced in both developed and developing regions. This growth is further supported by healthcare systems emphasizing preventive care and early diagnosis to mitigate the rising costs of treating advanced CVD.

How Is Technology Revolutionizing the Angiography Devices Market?

Technological advancements are playing a pivotal role in enhancing the capabilities of angiography devices, making them more efficient and safer for patients. One major development is the integration of digital imaging technology, which allows for higher-resolution images and real-time monitoring during procedures. The use of 3D and 4D imaging systems is transforming the way cardiologists assess blood vessels and coronary blockages, enabling more precise interventions. Another innovation is the development of minimally invasive catheter-based angiography systems, which reduce patient recovery times and minimize risks associated with traditional invasive angiography. These technological improvements are not only enhancing diagnostic accuracy but also expanding the scope of angiography into peripheral vascular conditions and neurology, thereby broadening the market`s reach.

What Role Do Regulations Play in the Adoption of Angiography Devices?

Stringent regulatory requirements are critical to the angiography devices market, as patient safety is paramount in cardiovascular interventions. Regulatory bodies like the FDA and European CE mark demand rigorous testing and validation of these devices to ensure they meet safety and performance standards. These regulations are particularly important given the risks associated with angiographic procedures, such as radiation exposure and contrast-induced nephropathy. Manufacturers are under pressure to develop devices that minimize these risks while complying with strict guidelines. Furthermore, advancements in imaging technologies and the development of contrast-free angiography techniques are being driven by regulatory encouragement, further shaping the future of the market. Compliance with these standards ensures widespread adoption of new, safer angiography systems across global healthcare settings.

What Factors Are Propelling the Growth of the Angiography Devices Market?

The growth in the angiography devices market is driven by several factors, including the rising incidence of cardiovascular diseases, increasing awareness of early diagnostic tools, and advancements in imaging technology. The growing elderly population, who are more prone to heart-related ailments, has significantly boosted demand for angiography procedures. In addition, technological advancements, such as the introduction of hybrid operating rooms that combine surgical and diagnostic functions, are enhancing the efficiency and accuracy of cardiovascular interventions, thereby increasing the demand for state-of-the-art angiography systems. Expanding healthcare infrastructure in emerging markets, coupled with increased government investment in healthcare technologies, is also driving growth. Finally, the growing preference for minimally invasive procedures has accelerated the adoption of newer, safer angiography devices across a range of medical specialties.

SCOPE OF STUDY:

The report analyzes the Angiography Devices market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:
End-Use (Hospitals & Clinics, Diagnostic & Imaging Centers, Research Institutes); Procedure (Coronary Angiography, Endovascular Angiography, Neuroangiography, Onco-Angiography, Other Angiography Procedures); Product (Angiography Systems, Angiography Contrast Media, Vascular Closure Devices, Angiography Balloons, Angiography Catheters, Angiography Guidewires, Angiography Accessories); Technology (X-Ray Angiography, CT Angiography, MR Angiography, Other Angiography Technologies)

Geographic Regions/Countries:
World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 42 Featured) -

• Abbott Laboratories, Inc.
• AngioDynamics, Inc.
• B. Braun Melsungen AG
• Boston Scientific Corporation
• Canon Medical Systems Corporation
• Cordis Corporation
• GE Healthcare
• Koninklijke Philips NV
• Medtronic PLC
• Shimadzu Corporation
• Siemens Healthineers

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by artificially increasing the COGS, reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

We are diligently following expert opinions of leading Chief Economists (14,949), Think Tanks (62), Trade & Industry bodies (171) worldwide, as they assess impact and address new market realities for their ecosystems. Experts and economists from every major country are tracked for their opinions on tariffs and how they will impact their countries.

We expect this chaos to play out over the next 2-3 months and a new world order is established with more clarity. We are tracking these developments on a real time basis.

As we release this report, U.S. Trade Representatives are pushing their counterparts in 183 countries for an early closure to bilateral tariff negotiations. Most of the major trading partners also have initiated trade agreements with other key trading nations, outside of those in the works with the United States. We are tracking such secondary fallouts as supply chains shift.

To our valued clients, we say, we have your back. We will present a simplified market reassessment by incorporating these changes!

APRIL 2025: NEGOTIATION PHASE

Our April release addresses the impact of tariffs on the overall global market and presents market adjustments by geography. Our trajectories are based on historic data and evolving market impacting factors.

JULY 2025 FINAL TARIFF RESET

Complimentary Update: Our clients will also receive a complimentary update in July after a final reset is announced between nations. The final updated version incorporates clearly defined Tariff Impact Analyses.

Reciprocal and Bilateral Trade & Tariff Impact Analyses:

USA
CHINA
MEXICO
CANADA
EU
JAPAN
INDIA
176 OTHER COUNTRIES.

Leading Economists - Our knowledge base tracks 14,949 economists including a select group of most influential Chief Economists of nations, think tanks, trade and industry bodies, big enterprises, and domain experts who are sharing views on the fallout of this unprecedented paradigm shift in the global econometric landscape. Most of our 16,491+ reports have incorporated this two-stage release schedule based on milestones.

Please note: Reports are sold as single-site single-user licenses. Electronic versions require 24-48 hours as each copy is customized to the client with digital controls and custom watermarks. The Publisher uses digital controls protecting against copying and printing is restricted to one full copy to be used at the same location.

The latest version of Adobe Acrobat Reader is required to view the report. Upon ordering an electronic version, the Publisher will provide a link to download the purchased report.

Prior to fulfillment of an order, the client will be required to sign a document detailing the purchase terms for a publication from this publisher.